Annals of Clinical Trials and Vaccines Research | Volume 6, Issue 6

Perspectivep. 161-162

Development and Hereditary Guideline of the Insusceptible Framework

Author(s): Khalid Shah

DOI: 10.37532/ACTVR.2023.13(6).161-162

Perspectivep. 163-164

Ethical Considerations in Vaccine Trials with Vulnerable Populations

Author(s): Sechul Chun

DOI: 10.37532/ACTVR.2023.13(6).163-164

Perspectivep. 165-166

Speed vs. Safety: Navigating the Vaccine Development Landscape

Author(s): Ercan Cacan

DOI: 10.37532/ACTVR.2023.13(6).165-166

Perspectivep. 173-174

The Role of Public-Private Partnerships in Vaccine Development

Author(s): Bin Yu

DOI: 10.37532/ACTVR.2023.13(6).173-174

Perspectivep. 169-170

Adaptive Trial Designs in the Context of Emerging Infectious Diseases

Author(s): Carel Viljoen

DOI: 10.37532/ACTVR.2023.13(6).169-170

Perspectivep. 171-172

Long-Term Monitoring and Post-Market Surveillance

Author(s): Guanglei Xun

DOI: 10.37532/ACTVR.2023.13(6).171-172

Perspectivep. 175-177

Inflammatory Biomarkers: Unravelling the Key Players in Disease Diagnosis and Management

Author(s): Marine E. Gasparian

DOI: 10.37532/ACTVR.2023.13(6).175-177

Opinion Articlep. 178-179

Revolutionizing Vaccine Design through AI and Machine Learning

Author(s): Fienke L. Ditzel

DOI: 10.37532/ACTVR.2023.13(6).178-179

Perspectivep. 180-181

Nanoparticle Vaccines: Revolutionizing Immunization in the Modern Era

Author(s): Siew Ching Ngai

DOI: 10.37532/ACTVR.2023.13(6).180-181

Opinion Articlep. 167-168

The Role of Social Media in Shaping Perceptions of Vaccines

Author(s): Jan Arvidsen

DOI: 10.37532/ACTVR.2023.13(6).167-168

Volume 6, Issue 6